Work

Prospective phase II trial in patients with first relapse of high-grade astrocytoma using TVB-2640 in combination with bevacizumab versus bevacizumab alone.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.2064

Authors: Brandon Konkel, Laura D Caflisch, Adolfo Enrique Diaz Duque, Joel Michalek, Qianqian Liu, Andrew Jacob Brenner

Institutions: The University of Texas at San Antonio Health Science Center, Mays Cancer Center at UT Health San Antonio

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947040293

Cites:

Cited by: 9

Related to: 10